In Vitro Elution and Antibacterial Efficacy of Antibiotic-Loaded Bone Cement wif Different Viscosities: A Comparative Study

When a knee replacement fails because of a deep infection, the solution is rarely simple. Surgeons must remove the infected metal and plastic, clean the area thoroughly, and then fill the empty space with a temporary plug made of bone cement mixed with powerful antibiotics. This plug, known as a spacer, acts as a local drug delivery system, releasing medicine directly into the joint to kill the bacteria that have formed a slimy, protective shield on the bone. The bacteria most feared in these situations are a tough strain called MRSA, which resists many standard treatments. For decades, doctors have relied on different types of this cement, some thick and some slightly thinner, hoping to find the perfect balance between how well the cement holds together and how effectively it releases its antibiotic payload. The goal is to flood the area with enough medicine to wipe out the infection without wasting the drug too quickly or releasing it all at once.

A team of researchers in China set out to solve a specific puzzle in this process: does the thickness, or viscosity, of the cement matter when it comes to killing bacteria? They focused on two common types of cement—one medium-thick and one medium-high-thick—and mixed each with three different amounts of the antibiotic vancomycin. They created small cylinders of these mixtures, ranging from a low dose of 2 grams to a high dose of 6 grams per 40 grams of cement. They then placed these cylinders in a sterile fluid that mimics the environment inside a human joint and watched how the antibiotic washed out over time. To see if the fluid was actually killing the bacteria, they took samples from the fluid after 12 weeks and mixed them with a culture of MRSA, counting how many bacteria survived compared to a control group that received no antibiotic treatment.

The results offered a clear picture of what works and what does not. The researchers found that the thickness of the cement made almost no difference in how well the bacteria were killed. Whether the cement was medium-thick or medium-high-thick, the survival rate of the bacteria depended almost entirely on how much antibiotic was packed inside. When they used the lowest amount, 2 grams, the cement killed very few bacteria, with an inhibition rate of only about 11 to 14 percent. This suggests that a low dose might not be strong enough to stop the infection on its own. When they increased the dose to 4 grams, the effectiveness jumped significantly, killing roughly 46 percent of the bacteria. The highest dose, 6 grams, showed the highest inhibition rate at about 60 percent, but the study also revealed a hidden risk with this level. In the thicker cement, the drug tended to rush out all at once during the first day, followed by a much slower release later on. This "burst" could be dangerous because it might leave the joint without enough medicine when the infection is still active a few weeks later. The 4-gram dose, by contrast, provided a steady, reliable release of the drug without that dangerous initial spike. The study concluded that for a patient facing a difficult knee infection, the best strategy is likely to use a moderate amount of antibiotic—4 grams—mixed into the cement. This approach offers a strong defense against the bacteria while maintaining a safe and steady flow of medicine, proving that in the fight against joint infections, a balanced dose is often more effective than the strongest one.